40. Pulmonary Arterial Hypertension Flashcards

1
Q

Drug list that can cause pulmonary arterial HTN

A

Cocaine
Fenfluramine
Methamphetamine/amphetamine
SSRI use during pregnancy (increase risk of persistent pulmonary hypertension of a newborn (PPHN))
Weight-loss drugs (diethylpropion, phendimetrazine, phentermine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Pulmonary HTN is characterized by mPAP ≥____ (normal range is ___)

A

≥25mmHg
Normal range 8-20 mmHg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

PAH stems from an imbalance in vasoconstrictor and vasodilator substances. Vasoconstrictor substances (e.g. ____) are increased and vasodilating substances (e.g. ____) are decreased

A

vasoconstrictor = endotheline-1, TXA2
Vasodilator = prostacyclins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

____ is the most common cause of death in pts who have PAH

A

HF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

S/sx of PAH

A

Fatigue, dyspnea
Others: chest pain syncope edema, tachycardia and/or Raynaud’s phenomenon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

T/F: There is no cure for PAH but there are treatment options and in some cases, a lung or heart transplant may be an option for younger patients

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Non-drug treatments for PAH

A

Sodium restriction (<2.4 grams/day)
Avoid meds that increase sodium/water retention (NSAIDs)
Influenza and pneumococcal vaccines recommended

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

____ is performed to confirm the diagnosis of PAH

A

Right heart catheterization

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

During a right heart catheterization, what meds are administered for vasoreactivity testing?

A

short-acting vasodilators (e.g. inhaled nitric oxide, IV epoprostenol, IV adenosine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What makes someone a responder during vasoreactivity testing? What treatment do you recommend for responders?

A

If mPAP falls by at least 10mmHg to an absolute value <40mmHg
Treatment: oral CCB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are common CCBs used in responders?

A

Long-acting nifedipine, diltiazem, and amlodipine
Verapamil is NOT recommended d/t more pronounced negative inotropic effects compared to diltiazem

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are treatment options for non-responders or responders who failed CCBs?

A

Prostacyclin analogues and receptor agonists, endothelin receptor antagonists (ERAs), PDE-5i, and/or soluble guanylate cyclase (sGC) stimulator

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Parenteral prostacyclin analogues, specifically ___, have shown to decrease mortality

A

IV epoprostenol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Supportive therapies for PAH may include ___ (for volume overload) and ___ (to improve cardiac output or control HR in Afib)

A

Loop diuretics
Diogxin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

T/F: PAH leads to a higher risk of bleeding

A

False - leads to a pro-thrombic state and increased risk of blood clots

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the preferred anticoagulation if needed in PAH pts?

A

Warfarin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

MOA of prostacycline analogues

A

Potent vasodilators and inhibitors of platelet aggregation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Which prostacyclin analogues can be administered by continuous IV at home using an ambulatory infusion pump?

A

Epoprostenol and treprostinil

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Treprostrinil (Remodulin) starting dose

A

1.25ng/kg/min, titrate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Epoprostenol (Flolan) starting dose

A

2ng/kg/min, titrate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

CI with epoprostenol

A

HF with decreased LVEJ

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

CI with treprostinil (oral)

A

severe hepatic impairment (Child-Pugh C)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Warnings for prostacyclin analogues

A

Vasodilation reactions (hypotension, flushing, HA, dizziness)
Rebound pulmonary HTN (with interruption or large decreases in dose, can be fatal)
Chronic IV infusions: sepsis and bloostreen infections
Treprostinil (Orenitram): PO ghost shell, can lodge in diverticulum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Side effects of prostacyclin analogues

A

Hypotension, flushing, jaw pain, HA, dizziness, N/V/D, edema, myalgia, tachycardia, flu-like syndrome, anxiety, tremor, thrombocytopenia
IV/SC infusions: infusion-site pain (esp SC Remodulin)
Treprostinil (inhaled) and iloprost: cough and mouth/throat irritation

25
Parenteral prostacyclin analogues (___,____,____) are very potent vasodilators; aoid interruptions and sudden large dose reductions
Epoprostenol - Flolan, Veletri Treprostinil - Remodulin
26
Which prostacyclin analogues require light protection before reconstitution and during infusion? Which ones require ice packs for stability?
Epoprostenol - protect from light before and during infusion Flolan (epoprostenol) - use ice packs for stability; Veletri and Remodulin are thermostable (no need for ice packs)
27
ng to mg conversion
1,000,000 ng = 1 mg
28
Endothelin receptor antagonists MOA
Endothelin is a vasoconstrictor with cellular proliferative effects ERA block endothelin receptors on pulmonary artery smooth muscle cells
29
What are examples of prostacyclin analogues and receptor agonists?
Epoprostenol (Flolan, Veletri) Treprostinil (Remodulin (continuous SC or IV), Tyvaso (inhalation), Orenitram (PO ER tab)) Iloprost (Ventavis (inhalation)) Selexipag (Uptravi (tab))
30
Boxed warnings for endothelin receptor antagonists
Teratogenic - must have neg pregnancy test prior to initiation of therapy and monthly thereafter Bosentan - hepatotoxicity Requires REMS program
31
Endothelin receptor antagonist examples
Bosentan (Tracleer) Ambrisentan (Letairis) Macitentan (Opsumit)
32
Contraindications for endothelin receptor antagonist
Pregnancy
33
Warnings for endothelin receptor antagonists
Hepatotoxicity Decrease Hgb/Hct Fluid retention (e.g. pulmonary edema, peripheral edema) Decreased sperm counts Bosentan: hypersensitivity reactions
34
Side effects for endothelin receptor antagonists
HA, URTI, flushing, hypotension
35
Bosentan is contraindicated in use with ___ or ___. Bosentan can decrease effectiveness of ____.
cylcosporine and glyburide hormonal contraceptives
36
Besentan is a substrate and inducer of CYP____ and___
3A4, 2C9
37
PDE-5i MOA
PDE-5 is responsible for the degradation of cGMP. Increased cGMP concentrations lead to pulmonary vasculature relaxation and vasodilation
38
Contraindications for PDE5i
Nitrates or riociguat Sildenafil (Revatio) - avoid taking with protease inhibitors (e.g. atazanavir, ritonavir, others)
39
Sildenafil brand for pulmonary HTN vs erectile dysfunction
Pulmonary HTN - Revatio ED - Viagra
40
Tadalafil brand for pulmonary HTN vs erectile dysfunction
Pulmonary HTN - Adcirca, Alyq, Tadliq ED - Cialis
41
Warnings for PDE-5i
Hearing loss, vision loss (NAION), hypotension, priapism (seek emergency medical care if erection > 4hrs), pulmonary edema
42
Side effects for PDE-5i
HA, epistaxis, flushing, dyspepsia, extremity/back pain, N/D
43
Use caution with concurrent use of ___ or other antihypertensives as PDE-5i increase risk of hypotension
Alpha-1 blockers
44
Soluble guanylate cyclase stimulator examples
Riociguat (Adempas)
45
Soluble guanylate cyclase stimulator (sGCs) MOA
SGC is a receptor for endogenous nitric oxide Riociguat (Adempas) sensitizes sGC to endogenous nitric oxide and directly stimulates the receptor at a different binding site >> increases cGMP, leading to relaxation
46
Riociguat is approved for use in both PAH and ___
CTEPH
47
Boxed warnings for riociguat (Adempas)
Teratogenic, must have negative pregnancy test prior to initiation and monthly REMS program only
48
Contraindications for riociguat (Adempas)
Pregnancy, use of PDE-5i or nitrates
49
Warnings for riociguat (Adempas)
Hypotension, bleeding, pulmonary edema
50
Side effects for riociguat (Adempas)
HA, dyspepsia, dizziness, N/V/D
51
Riociguat should be separated from antacids by ___
>1hr
52
Riociguate should not be administered within ___ hrs of sildenafil or within ___ hrs before or ___ after tadalafil
within 24 hrs of sildenafil 24hrs before or 48 hrs after tadalafil
53
Smoking (increases/decreases) riociguat clearance; dose may need to be (increased/decreased) with smoking cessation
increases decreased
54
Define pulmonary fibrosis (PF)
scarred and damaged lung tissue
55
S/sx pulmonary fibrosis
External dyspnea with a nonproductive cough As condition worsens, breathing becomes more labored
56
Drugs that can cause pulmonary fibrosis
Amiodarone/dronedarone Bleomycin Busulfan Carmustine Lomustine Other: nitrofurantoin, sulfasalazine
57
Often the contributing factor for pulmonary fibrosis is not identified and it is called idiopathic pulmonary fibrosis (IPF). What are the 2 drugs no available for IPF?
Pirfenidone (Esbriet) and nintedanib (Ofev) - slows the rate of decline in lung function
58
Which meds for PAH require monthly pregnancy tests + REMS?
ERAs - Bosentan, ambrisentan, macitentan sGC stimulator - Riociguat
59
Patient failed on diltiazem treatment for PAH but is currently on a nitrate. Which meds can they NOT use?
Riociguat and PDE-5i